Synthesis and Evaluation of Dihydropyrroloquinolines That Selectively Antagonize P-Glycoprotein
- 10 February 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (6) , 1413-1422
- https://doi.org/10.1021/jm0303204
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multidrug Resistance Reversal AgentsJournal of Medicinal Chemistry, 2003
- The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoproteinBritish Journal of Pharmacology, 1999
- The biology of the P-glycoproteinsThe Journal of Membrane Biology, 1995
- Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) geneEuropean Journal Of Cancer, 1994
- Expression of an inward-rectifying potassium channel by the Arabidopsis KAT1 cDNAScience, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and PharmacodynamicsJNCI Journal of the National Cancer Institute, 1989
- ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.Proceedings of the National Academy of Sciences, 1988
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983